APGE is currently covered by 12 analysts with an average price target of $133.01. This is a potential downside of $2.06 (-1.53%) from yesterday's end of day stock price of $135.07.
Apogee Therapeutics's activity chart (see below) currently has 53 price targets and 77 ratings on display. The stock rating distribution of APGE is 82.35% BUY and 17.65% HOLD.
Analysts' price targets on this stock were met 88.41% of the time, taking 264.61 days on average.
Highest price target for APGE is $137, Lowest price target is $116, average price target is $133.01.
Most recent stock forecast was given by DANIELLE BRILL from TRUIST on 12-Aug-2026. First documented stock forecast 07-Aug-2023.
Currently out of the existing stock ratings of APGE, 28 are a BUY (82.35%), 6 are a HOLD (17.65%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 17-Mar-2026
$135
$-0.07 (-0.05%)
$81
3 months 8 days ago
(12-Aug-2026)
3/3 (100%)
$0.55 (0.41%)
11
Buy Since 19-Dec-2023
$137
3 months 9 days ago
(11-Aug-2026)
8/12 (66.67%)
$59.25 (76.21%)
366
Buy Since 21-Oct-2025
$135
$2.45 (1.85%)
$110
4 months 28 days ago
(24-Jun-2026)
2/3 (66.67%)
$2.31 (1.74%)
165
Buy Since 08-Aug-2023
$160
4 months 28 days ago
(24-Jun-2026)
4/5 (80%)
$87 (119.18%)
409
Buy Since 08-Aug-2023
$135
$2.45 (1.85%)
$86
4 months 28 days ago
(24-Jun-2026)
3/4 (75%)
$2.31 (1.74%)
394
What is APGE (Apogee Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on APGE (Apogee Therapeutics)?
Which analyst has the most public recommendations on APGE (Apogee Therapeutics)?
Which analyst is the currently most bullish on APGE (Apogee Therapeutics)?
Which analyst is the currently most reserved on APGE (Apogee Therapeutics)?